| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pathology,* Institute of Frontier Medical Science, and the Department of Toxicology, School of Preventive Medicine, Jilin University, Changchun, Peoples Republic of China; and the Departments of Medicine, Pharmacology, and Toxicology, University of Louisville, Louisville, Kentucky
Advanced glycation end-products (AGEs) play a critical role in diabetic nephropathy by stimulating extracellular matrix (ECM) synthesis. Connective tissue growth factor (CTGF) is a potent inducer of ECM synthesis and increases in the diabetic kidneys. To determine the critical role of CTGF in AGE-induced ECM accumulation leading to diabetic nephropathy, rats were given AGEs by intravenous injection for 6 weeks. AGE treatment induced a significant renal ECM accumulation, as shown by increases in periodic acid-Schiff-positive materials, fibronectin, and type IV collagen (Col IV) accumulation in glomeruli, and a mild renal dysfunction, as shown by increases in urinary volume and protein content. AGE treatment also caused significant increases in renal CTGF and transforming growth factor (TGF)-ß1 mRNA and protein expression. Direct exposure of rat mesangial cells to AGEs in vitro significantly induced increases in fibronectin and Col IV production, which could be completely prevented by pretreatment with anti-CTGF antibody. AGE treatment also significantly increased both TGF-ß1 and CTGF mRNA expression; however, inhibition of TGF-ß1 mRNA expression by shRNA or neutralization of TGF-ß1 protein by anti-TGF-ß1 antibody did not significantly prevent AGE-increased expression of CTGF mRNA and protein. These results suggest that AGE-induced CTGF expression, predominantly through a TGF-ß1-independent pathway, plays a critical role in renal ECM accumulation leading to diabetic nephropathy.
This article has been cited by other articles:
 |
|
 |
|
  A. C.K. Chung, H. Zhang, Y.-Z. Kong, J.-J. Tan, X. R. Huang, J. B. Kopp, and H. Y. Lan Advanced Glycation End-Products Induce Tubular CTGF via TGF-{beta}-Independent Smad3 Signaling J. Am. Soc. Nephrol., February 1, 2010; 21(2): 249 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Rane, Y. Song, S. Jin, M. T. Barati, R. Wu, H. Kausar, Y. Tan, Y. Wang, G. Zhou, J. B. Klein, et al. Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy Am J Physiol Renal Physiol, January 1, 2010; 298(1): F49 - F61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, Y. Tan, W. Guo, C. Li, S. Ji, X. Li, and L. Cai Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation Am J Physiol Endocrinol Metab, December 1, 2009; 297(6): E1366 - E1377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. K. Leung, L. Y. Y. Chan, K. Y. Tam, S. C. W. Tang, M. F. Lam, A. S. Cheng, K. M. Chu, and K. N. Lai Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis Nephrol. Dial. Transplant., February 1, 2009; 24(2): 458 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tian, C. Li, J. Qi, P. Fu, X. Yu, X. Li, and L. Cai Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-{beta}1-mediated renal fibrosis and dysfunction Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1234 - E1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Kuiper, R. van Zijderveld, P. Roestenberg, K. M. Lyons, R. Goldschmeding, I. Klaassen, C. J.F. Van Noorden, and R. O. Schlingemann Connective Tissue Growth Factor Is Necessary for Retinal Capillary Basal Lamina Thickening in Diabetic Mice J. Histochem. Cytochem., August 1, 2008; 56(8): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, R. Yang, B. Tinner, A. Choudhry, N. Schutze, and B. Chaqour Cysteine-Rich Protein 61 and Connective Tissue Growth Factor Induce Deadhesion and Anoikis of Retinal Pericytes Endocrinology, April 1, 2008; 149(4): 1666 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Berthier, P. R. Wahl, M. L. Hir, H.-P. Marti, U. Wagner, H. Rehrauer, R. P. Wuthrich, and A. L. Serra Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant., March 1, 2008; 23(3): 880 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aragno, R. Mastrocola, G. Alloatti, I. Vercellinatto, P. Bardini, S. Geuna, M. G. Catalano, O. Danni, and G. Boccuzzi Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats Endocrinology, January 1, 2008; 149(1): 380 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Kuiper, J. M. Hughes, R. J. Van Geest, I. M. C. Vogels, R. Goldschmeding, C. J. F. Van Noorden, R. O. Schlingemann, and I. Klaassen Effect of VEGF-A on Expression of Profibrotic Growth Factor and Extracellular Matrix Genes in the Retina Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4267 - 4276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Baran, J. M. Opalek, S. McMaken, C. A. Newland, J. M. O'Brien Jr., M. G. Hunter, B. D. Bringardner, M. M. Monick, D. R. Brigstock, P. C. Stromberg, et al. Important Roles for Macrophage Colony-stimulating Factor, CC Chemokine Ligand 2, and Mononuclear Phagocytes in the Pathogenesis of Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 78 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yu, C. Li, X. Li, and L. Cai Rosiglitazone Prevents Advanced Glycation End Products-Induced Renal Toxicity Likely through Suppression of Plasminogen Activator Inhibitor-1 Toxicol. Sci., April 1, 2007; 96(2): 346 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Uribarri and K. R. Tuttle Advanced Glycation End Products and Nephrotoxicity of High-Protein Diets Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1293 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lang, C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon (Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms. Physiol Rev, October 1, 2006; 86(4): 1151 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Burns, S. M. Twigg, J. M. Forbes, J. Pete, C. Tikellis, V. Thallas-Bonke, M. C. Thomas, M. E. Cooper, and P. Kantharidis Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product-Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2484 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Qi, X. Chen, T. S. Polhill, S. Sumual, S. Twigg, R. E. Gilbert, and C. A. Pollock TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway Am J Physiol Renal Physiol, March 1, 2006; 290(3): F703 - F709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, Y. Song, L. Elsherif, Z. Song, G. Zhou, S. D. Prabhu, J. T. Saari, and L. Cai Cardiac Metallothionein Induction Plays the Major Role in the Prevention of Diabetic Cardiomyopathy by Zinc Supplementation Circulation, January 31, 2006; 113(4): 544 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
